FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2612762854> ?p ?o ?g. }

• W2612762854 abstract "Background: Children in remission from acute lymphoblastic leukemia (ALL) have a high prevalence of immune system defects; one of them is the decrease of vaccine-induced antibody seropositivity rates. This antibody deficiency may place children with ALL at risk for the development of vaccine- preventable diseases, even after completion of chemotherapy, and they could function as a reservoir for additional spread of these diseases in the population. The aim of the present study was the assessment of the levels of vaccine- induced antibodies against measles and rubella viruses in ALL children following chemotherapy. Subjects and methods: Antibody levels against measles and rubella vaccine viruses were evaluated by ELISA technique in 96 children with ALL after completion of chemotherapy, in addition to 30 healthy children (non cancer controls of matched age and sex). Results: All healthy children were seropositive for measles and rubella antibodies. On the other hand, out of 96 children who received chemotherapy, only 19 (19.8%) were seropositive for measles antibodies, while 70 (72.9%) were seropositive for rubella antibodies. Most of measles seropositive cases (57.9%) had low levels of measles antibodies while among control group most children (56.7%) had high levels of measles antibodies. Similarly among children who received chemotherapy, most of the seropositive cases (45.7%) had low levels of rubella antibodies, while among control group, most of children (36.6%) had high levels of rubella antibodies. Seropositivity rate of measles was found to be related to the age at diagnosis and disease duration, while that of rubella was found to be related to the disease duration only. Conclusion and recommendations: Most of children who have been treated with chemotherapy for ALL had lost measles antibodies and to less extent rubella antibodies. Among seropositive cases, levels of measles and rubella antibodies are low following treatment with chemotherapy compared to levels among normal controls. Therefore, revaccination of children with ALL following completion of chemotherapeutic treatment against measles and rubella is recommended. Key words: Acute lymphoblastic leukemia, measles, rubella, vaccine." @default.
• W2612762854 created "2017-05-19" @default.
• W2612762854 creator A5015993615 @default.
• W2612762854 creator A5021218045 @default.
• W2612762854 creator A5047627161 @default.
• W2612762854 creator A5078532688 @default.
• W2612762854 date "2013-04-01" @default.
• W2612762854 modified "2023-09-27" @default.
• W2612762854 title "Measles and Rubella Vaccine Antibody Levels in Children with Acute Lymphoblastic Leukemia Following Chemotherapy" @default.
• W2612762854 doi "https://doi.org/10.21608/jhiph.2013.19987" @default.
• W2612762854 hasPublicationYear "2013" @default.
• W2612762854 type Work @default.
• W2612762854 sameAs 2612762854 @default.
• W2612762854 citedByCount "0" @default.
• W2612762854 crossrefType "journal-article" @default.
• W2612762854 hasAuthorship W2612762854A5015993615 @default.
• W2612762854 hasAuthorship W2612762854A5021218045 @default.
• W2612762854 hasAuthorship W2612762854A5047627161 @default.
• W2612762854 hasAuthorship W2612762854A5078532688 @default.
• W2612762854 hasBestOaLocation W26127628541 @default.
• W2612762854 hasConcept C159654299 @default.
• W2612762854 hasConcept C187212893 @default.
• W2612762854 hasConcept C203014093 @default.
• W2612762854 hasConcept C22070199 @default.
• W2612762854 hasConcept C2776438120 @default.
• W2612762854 hasConcept C2778814567 @default.
• W2612762854 hasConcept C2780657872 @default.
• W2612762854 hasConcept C71924100 @default.
• W2612762854 hasConceptScore W2612762854C159654299 @default.
• W2612762854 hasConceptScore W2612762854C187212893 @default.
• W2612762854 hasConceptScore W2612762854C203014093 @default.
• W2612762854 hasConceptScore W2612762854C22070199 @default.
• W2612762854 hasConceptScore W2612762854C2776438120 @default.
• W2612762854 hasConceptScore W2612762854C2778814567 @default.
• W2612762854 hasConceptScore W2612762854C2780657872 @default.
• W2612762854 hasConceptScore W2612762854C71924100 @default.
• W2612762854 hasLocation W26127628541 @default.
• W2612762854 hasOpenAccess W2612762854 @default.
• W2612762854 hasPrimaryLocation W26127628541 @default.
• W2612762854 hasRelatedWork W1995135241 @default.
• W2612762854 hasRelatedWork W2020211856 @default.
• W2612762854 hasRelatedWork W2068579595 @default.
• W2612762854 hasRelatedWork W2087591117 @default.
• W2612762854 hasRelatedWork W2131997468 @default.
• W2612762854 hasRelatedWork W2158138659 @default.
• W2612762854 hasRelatedWork W2312182606 @default.
• W2612762854 hasRelatedWork W2358905497 @default.
• W2612762854 hasRelatedWork W2388364701 @default.
• W2612762854 hasRelatedWork W2397790169 @default.
• W2612762854 hasRelatedWork W2409093899 @default.
• W2612762854 hasRelatedWork W2417777630 @default.
• W2612762854 hasRelatedWork W2887273946 @default.
• W2612762854 hasRelatedWork W2898809664 @default.
• W2612762854 hasRelatedWork W2913965461 @default.
• W2612762854 hasRelatedWork W2954951103 @default.
• W2612762854 hasRelatedWork W2978993017 @default.
• W2612762854 hasRelatedWork W3012119665 @default.
• W2612762854 hasRelatedWork W3120789982 @default.
• W2612762854 hasRelatedWork W3178739414 @default.
• W2612762854 isParatext "false" @default.
• W2612762854 isRetracted "false" @default.
• W2612762854 magId "2612762854" @default.
• W2612762854 workType "article" @default.